1. Home
  2. ZJYL vs IPSC Comparison

ZJYL vs IPSC Comparison

Compare ZJYL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

N/A

Current Price

$3.31

Market Cap

248.6M

ML Signal

N/A

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

N/A

Current Price

$1.18

Market Cap

248.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZJYL
IPSC
Founded
2006
2019
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.6M
248.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ZJYL
IPSC
Price
$3.31
$1.18
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $4.75
AVG Volume (30 Days)
220.2K
★ 876.8K
Earning Date
08-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 91.30
EPS
★ N/A
N/A
Revenue
N/A
★ $109,164,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.40
★ N/A
Revenue Growth
N/A
★ 1556.76
52 Week Low
$0.10
$0.48
52 Week High
$4.95
$2.97

Technical Indicators

Market Signals
Indicator
ZJYL
IPSC
Relative Strength Index (RSI) 56.92 34.74
Support Level $1.86 N/A
Resistance Level $3.74 $2.45
Average True Range (ATR) 0.51 0.19
MACD -0.03 -0.04
Stochastic Oscillator 43.49 2.07

Price Performance

Historical Comparison
ZJYL
IPSC

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: